FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),

Updated on: June 17,2024

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),

Updated on:June 17,2024

Osteoarthritis: Carbohydrate-binding protein promotes inflammation

by Medical University of ViennaFunction and effect of galectin-1 in osteoarthritis identified for the very first timeMore and more people, particularly older people, are suffering from osteoarthr

Updated on: March 24,2024

Osteoarthritis: Carbohydrate-binding protein promotes inflammation

by Medical University of ViennaFunction and effect of galectin-1 in osteoarthritis identified for the very first timeMore and more people, particularly older people, are suffering from osteoarthr

Updated on:March 24,2024

Cell adaptation in critically ill could be difference between life and death, new study shows

by Amy King,University of PlymouthGraphical abstract. Credit:Redox Biology(2021). DOI: 10.1016/j.redox.2021.101907Creating the best conditions for cells to make energy and survive cr

Updated on: May 06,2024

Cell adaptation in critically ill could be difference between life and death, new study shows

by Amy King,University of PlymouthGraphical abstract. Credit:Redox Biology(2021). DOI: 10.1016/j.redox.2021.101907Creating the best conditions for cells to make energy and survive cr

Updated on:May 06,2024

Proteinuria level predicts renal outcome in lupus nephritis

(HealthDay)—Proteinuria levels at 12 months are the best predictor of long-term renal outcome in patients with lupus nephritis, according to a study published in the May issue ofArthritis &

Updated on: March 24,2024

Proteinuria level predicts renal outcome in lupus nephritis

(HealthDay)—Proteinuria levels at 12 months are the best predictor of long-term renal outcome in patients with lupus nephritis, according to a study published in the May issue ofArthritis &

Updated on:March 24,2024

Patients with rheumatoid arthritis have increased anxiety during pandemic

For patients with rheumatoid arthritis (RA), anxiety increased during the COVID-19 pandemic, as did suspected depression, according to a letter to the editor published online Jan. 27 inRheumatol

Updated on: June 28,2024

Patients with rheumatoid arthritis have increased anxiety during pandemic

For patients with rheumatoid arthritis (RA), anxiety increased during the COVID-19 pandemic, as did suspected depression, according to a letter to the editor published online Jan. 27 inRheumatol

Updated on:June 28,2024

Identification of LZTR1 leads to novel insights into RAS-driven diseases

by VIB (the Flanders Institute for Biotechnology)Cancer cell during cell division. Credit: National Institutes of HealthMutations in RAS proteins initiate many of the most aggressive tumors, and

Updated on: April 16,2024

Identification of LZTR1 leads to novel insights into RAS-driven diseases

by VIB (the Flanders Institute for Biotechnology)Cancer cell during cell division. Credit: National Institutes of HealthMutations in RAS proteins initiate many of the most aggressive tumors, and

Updated on:April 16,2024

Lower doses of rheumatoid arthritis drugs may work for some

by Amy Norton, Healthday ReporterStudy found many patients with early stage disease stayed in remission with less medication.(HealthDay)—Some people in the early stages of rheumatoid arthritis may be

Updated on: March 24,2024

Lower doses of rheumatoid arthritis drugs may work for some

by Amy Norton, Healthday ReporterStudy found many patients with early stage disease stayed in remission with less medication.(HealthDay)—Some people in the early stages of rheumatoid arthritis may be

Updated on:March 24,2024

Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actions

by University of OsloREW enhances phagocytosis of gram-positive and killing of gram-negative bacteria. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46321-9Antibody ther

Updated on: March 19,2024

Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actions

by University of OsloREW enhances phagocytosis of gram-positive and killing of gram-negative bacteria. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46321-9Antibody ther

Updated on:March 19,2024

Adherence to mediterranean diet not linked to risk of RA

(HealthDay)—Adherence to a Mediterranean diet is not associated with incidence of rheumatoid arthritis (RA) in U.S. women, according to a study published in the May issue ofArthritis Care &

Updated on: April 08,2024

Adherence to mediterranean diet not linked to risk of RA

(HealthDay)—Adherence to a Mediterranean diet is not associated with incidence of rheumatoid arthritis (RA) in U.S. women, according to a study published in the May issue ofArthritis Care &

Updated on:April 08,2024

New pathway in immune defense discovered: Interaction of monocytes and platelets decoded

by Inka Väth,University Hospital Bonn(from left) Dr. Ibrahim Hawwari, Prof. Bernardo Franklin and Lukas Roßnagel discover new intercellular communication mechanism in which blood platelets, so-c

Updated on: July 09,2024

New pathway in immune defense discovered: Interaction of monocytes and platelets decoded

by Inka Väth,University Hospital Bonn(from left) Dr. Ibrahim Hawwari, Prof. Bernardo Franklin and Lukas Roßnagel discover new intercellular communication mechanism in which blood platelets, so-c

Updated on:July 09,2024

Cell-compressing technique a new path in immunotherapy

by Zach Winn,Massachusetts Institute of TechnologyTo engineer cell functions, SQZ Biotech uses tiny channels on a microfluidic chip to squeeze cells so they can be penetrated by specific molecul

Updated on: April 09,2024

Cell-compressing technique a new path in immunotherapy

by Zach Winn,Massachusetts Institute of TechnologyTo engineer cell functions, SQZ Biotech uses tiny channels on a microfluidic chip to squeeze cells so they can be penetrated by specific molecul

Updated on:April 09,2024

'New era and treatment of breast cancer': AI is helping detect breast cancer earlier

by Michelle Marchante, Miami HeraldThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom

Updated on: March 13,2024

'New era and treatment of breast cancer': AI is helping detect breast cancer earlier

by Michelle Marchante, Miami HeraldThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom

Updated on:March 13,2024